The company provides integrated data collection using wearables, spot assessment tools, and point-of-care blood analysis. They specialize in digital therapeutics, digital health, and digital care companions. Alacrity Care's data-driven software improves self-management of side effects for cancer patients and allows healthcare providers to monitor symptoms and vitals in real-time. They are also developing digital biomarkers for clinical oncology, which powers a well-designed RPM solution for immune-related drug toxicity management, and helps draw profound data insights from select patient cohorts.